NanoViricides (NNVC) Ownership - Who Owns NanoViricides?

610 Followers

NanoViricides (NNVC) Ownership Overview

3.18% Mutual Funds

0.64% Other Institutional Investors

2.37% ETFs

93.81% Public Companies and

Individual Investors

The ownership structure of NanoViricides (NNVC) stock is a mix of institutional, retail, and individual investors. Approximately 6.19% of the company’s stock is owned by Institutional Investors, and 93.81% is owned by Public Companies and Individual Investors.

The ownership structure of NanoViricides (NNVC) stock is a mix of institutional, retail, and individual investors. Approximately 3.01% of the company’s stock is owned by Institutional Investors, 3.18% is owned by Insiders, and 93.81% is owned by Public Companies and Individual Investors.

Top Shareholders

# of Shares	Type	% Holding	Value
511,477	Institution	2.37%	746,756
511,477	Institution	2.37%	746,756
139,922	Institution	0.65%	204,286
36,039	Institution	0.17%	52,617

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
511,477	Institution	2.37%	746,756
139,922	Institution	0.65%	204,286
36,039	Institution	0.17%	52,617

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	344,656	Institution	1.60%	314,361
Vanguard Extended Market ETF	166,821	Institution	0.77%	152,157

FAQ

Who Owns NanoViricides (NNVC)?

Currently, no data Available

What percentage of NanoViricides (NNVC) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.64% of NanoViricides (NNVC) stock is held by institutional investors.

What percentage of NanoViricides (NNVC) stock is held by retail investors?

According to the latest TipRanks data, approximately 93.81% of NanoViricides (NNVC) stock is held by retail investors.

Who owns the most shares of NanoViricides (NNVC)?

VANGUARD INDEX FUNDS owns the most shares of NanoViricides (NNVC).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.